COVID-19疫情期间选择根治性前列腺切除术患者的管理:国际加速共识声明
该国际加速共识针对非转移性前列腺癌选择手术的患者,通过三轮调查(共识阈值≥80%)制定手术优先级标准和疫情下管理路径。共识认为若手术延迟不可避免(>3-6个月),应重新配置前列腺癌管理路径,并提出「COVID-19冷区」等感染防控措施以降低院内感染风险。
要点
- 手术延迟>3-6个月时建议重新配置前列腺癌管理路径
- 共识提出手术优先级标准及延迟治疗患者的管理路径
- 「COVID-19冷区」感染防控措施可降低根治性前列腺切除术的院内感染风险
核心结论
- 若手术管理不可避免延迟>3-6个月,推荐重新配置前列腺癌管理路径。
- 所提出的感染防控流程为在低COVID-19风险环境中实施根治性前列腺切除术提供框架。
研究设计与样本
- 加速共识流程结合COVID-19证据的系统综述及国际前列腺癌指南回顾。
- 国际前列腺癌专家小组(n=34)通过在线会议参与,共进行三轮调查,共识定义为≥80%同意。
主要发现
- 关于前列腺癌患者延迟管理的证据稀缺。
- 专家组100%同意应重新配置前列腺癌路径并制定措施预防手术患者院内COVID-19。
- 就手术优先级标准和延迟治疗患者的管理路径达成共识。
关键数值与推荐
- 共识阈值定义为≥80%同意。
- 手术延迟>3-6个月被视为显著延迟,此时推荐重新配置管理路径。
临床怎么用
- 对选择根治性前列腺切除术的非转移性前列腺癌患者,按共识优先级标准安排手术。
- 在疫情期间或地方性流行期间,采用「COVID-19冷区」等感染防控措施实施手术。
- 对延迟治疗的患者按共识管理路径进行随访和决策。
局限性
- 关于前列腺癌患者延迟管理的证据稀缺。
- 共识基于专家意见和在线调查,非直接临床结局证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Coronavirus disease-19 (COVID-19) pandemic caused delays in definitive treatment of patients with prostate cancer. Beyond the immediate delay a backlog for future patients is expected. The objective of this work is to develop guidance on criteria for prioritisation of surgery and reconfiguring management pathways for patients with non-metastatic prostate cancer who opt for surgical treatment. A second aim was to identify the infection prevention and control (IPC) measures to achieve a low likelihood of coronavirus disease 2019 (COVID-19) hazard if radical prostatectomy (RP) was to be carried out during the outbreak and whilst the disease is endemic. METHODS: We conducted an accelerated consensus process and systematic review of the evidence on COVID-19 and reviewed international guidance on prostate cancer. These were presented to an international prostate cancer expert panel (n = 34) through an online meeting. The consensus process underwent three rounds of survey in total. Additions to the second- and third-round surveys were formulated based on the answers and comments from the previous rounds. The Consensus opinion was defined as ≥80% agreement and this was used to reconfigure the prostate cancer pathways. RESULTS: Evidence on the delayed management of patients with prostate cancer is scarce. There was 100% agreement that prostate cancer pathways should be reconfigured and measures developed to prevent nosocomial COVID-19 for patients treated surgically. Consensus was reached on prioritisation criteria of patients for surgery and management pathways for those who have delayed treatment. IPC measures to achieve a low likelihood of nosocomial COVID-19 were coined as 'COVID-19 cold' sites. CONCLUSION: Reconfiguring management pathways for patients with prostate cancer is recommended if significant delay (>3-6 months) in surgical management is unavoidable. The mapped pathways provide guidance for such patients. The IPC processes proposed provide a framework for providing RP within an environment with low COVID-19 risk during the outbreak or when the disease remains endemic. The broader concepts could be adapted to other indications beyond prostate cancer surgery.
引用
- Tandogdu Z, Collins J, Shaw G, et al. Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement. BJU Int. 2021. PMID: 33185026. doi:10.1111/bju.15299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。